Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations

H. Richardson (Dundee (Angus), United Kingdom), C. Clarke (Dundee (Angus), United Kingdom), M. Lonergan (Dundee (Angus), United Kingdom), H. Barclay (Dundee (Angus), United Kingdom), M. Crichton (Dundee (Angus), United Kingdom), J. Pollock (Glasgow, United Kingdom), S. Finch (Dundee (Angus), United Kingdom), P. Billingham (Dundee (Angus), United Kingdom), F. Hussain (Dundee (Angus), United Kingdom), A. Mackenzie (Dundee (Angus), United Kingdom), D. Cassidy (Dundee (Angus), United Kingdom), M. Band (Dundee (Angus), United Kingdom), A. Smith (Glasgow, United Kingdom), M. Paracha (Blackpool, United Kingdom), G. Chowdhury (Edinburgh, United Kingdom), D. Dhasmana (Kirkcaldy, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), P. Short (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), A. Dicker (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom)

Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils

Session: COPD : inhaled corticosteroids, bronchodilators and eosinophils
Session type: E-poster session
Number: 3253

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Richardson (Dundee (Angus), United Kingdom), C. Clarke (Dundee (Angus), United Kingdom), M. Lonergan (Dundee (Angus), United Kingdom), H. Barclay (Dundee (Angus), United Kingdom), M. Crichton (Dundee (Angus), United Kingdom), J. Pollock (Glasgow, United Kingdom), S. Finch (Dundee (Angus), United Kingdom), P. Billingham (Dundee (Angus), United Kingdom), F. Hussain (Dundee (Angus), United Kingdom), A. Mackenzie (Dundee (Angus), United Kingdom), D. Cassidy (Dundee (Angus), United Kingdom), M. Band (Dundee (Angus), United Kingdom), A. Smith (Glasgow, United Kingdom), M. Paracha (Blackpool, United Kingdom), G. Chowdhury (Edinburgh, United Kingdom), D. Dhasmana (Kirkcaldy, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), P. Short (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), A. Dicker (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom). Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations. 3253

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

One year change in health status in patients with stable Chronic Obstructive Pulmonary Disease (COPD) under long-acting bronchodilators treatment Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017
Cardiovascular safety of fixed dose combination long acting bronchodilators in stable patients with Chronic Obstructive Pulmonary Disease. Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
Effectiveness of pulmonary rehabilitation initiated after exacerbation of Chronic Obstructive Pulmonary Disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018
The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision Source: Eur Respir J, 56 (1) 2000627; 10.1183/13993003.00627-2020 Year: 2020
Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD Source: International Congress 2018 – Pharmacological management of COPD Year: 2018
Home management of severe Chronic Obstructive Pulmonary Disease (COPD): results from a randomized controlled study in Italy Source: International Congress 2019 – Clinical implications of COPD management Year: 2019
Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014
“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018
Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 178s Year: 2002
ERS Short Guideline: Inhaled corticosteroid withdrawal in COPD Source: Virtual Congress 2020 – Airway diseases Year: 2020
Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
The implementation of a psychological support during the adaptation to Non Invasive Ventilation (NIV) in Chronic Obstructive Pulmonary Disease (COPD): a Randomized Controlled Trial Source: International Congress 2018 – Hot topics in non-invasive ventilation Year: 2018
The Aetiology of Acute Exacerbations in Chronic Obstructive Pulmonary Disease (AECOPD): A Systematic Literature Review (SLR) Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017
Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014
The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014